Hims & Hers Stock: Growth, Noise, and Where to Focus Now

[@sagig72]

Good video. Great company. Great stock. Glad you didn't mention Amazon.

[@outworkthework]

Pretty new to the company and the very volatile stock! Thanks for the analysis.

[@mattalksmoney]

I love HIMS. I bought at $6. But it is still cheap.

[@booboobear8119]

Nice! I bought at $8, $9, $17, $19 and $24 and will buy more!

[@forevertrolling682]

Great video. I agree with the fact that we need to think where this business will be like 5 years from now.

[@jeffreyharrison4045]

Thanks Travis!

[@richardneugebauer1244]

I have just 300 shares bought for 16,-USD. When the price falls under 20, I continue to buy.

[@JanetAlber]

I have been buying more of HIMS in every dip or retracement, Morgan Stanley initiated coverage on Hims & Hers Health (HIMS) with an overweight rating and a $42-per-share price target or maybe more than that said my portfolio advisor ' sophie kathryn jones ' i'm grateful.

[@MaryDavidlove2]

Appereantly you are right and i think these wall street gint's know more on the next bullish spark...does sophie work there or she's just a investment adivsor.

[@MichealJamesw]

​@@MaryDavidlove2 lol but Hims & Hers is operating in a dynamic and fast-growing market with significant potential. Its business model is innovative and strong revenue growth.

[@BryanJohn450]

@@MichealJamesw hmmm so surprise you don't know about ' sophie kathryn jones ' she's one of the top 20 consultant with great history, you can look her up on your browser.

[@power-bikes3875]

Hims is great. Still buying bigger dips🎉

[@GustavoPotier-tq8gj]

The EPS growth is outstanding, and in my top 3 stock with higher growth

[@Hazel66781]

Morgan Stanley initiated coverage on Hims & Hers Health (HIMS) with an overweight rating and a $42-per-share price target.

[@maxrates]

At every dip I'm buying more HIMS

[@no1no1655]

recent dip is a blip on this company, up > 250% since '19 values. Seems like a great long-term play

[@Black-Circle]

it's 5% of their business and they dont even sell triseptide ...they dont sell it!

[@edal3375]

❤

[@toorcicefist8018]

The real question is how much revenue is from Glp1s? The rest of your video means nothing without that answer. If the answer is 80 percent then all the people buying on this advice are in for big dissapointment once the supply of name brands catches up. This stock will tank. Please find that answer. All this other noise means nothing without that answer. Also, a fool sponsor only screams one thing at me after watching the Fools over their entire career. They pump the stocks they own and it pushes the share price. 100%.

[@asymmetricinvesting]

It's a very, very small percentage. They didn't even start selling GLP-1s until the end of Q2 2024. And the ENTIRE weight loss business was on a $100 million runrate at that time. It's maybe 5% of revenue in Q3. In that ballpark.

[@nonoo1111]

5% calm down

[@fizzyfish-k4q]

US stock market is cooked. We had a good run while it lasted.